Researchers analyzed data on children aged 3 month to 18 years with CAP who were hospitalized from May 2, 2011 to July 30, 2012.
They found empiric guideline-recommended therapy was applied to 76 percent of the patients. The differences in clinical outcomes — length of stay, cost of hospitalization and inpatient pharmacy cost — for patients who received guideline-recommended therapy and those who did not were not statistically significant.
Researchers concluded using guideline-recommended antibiotic therapy was not associated with improved clinical outcomes for pediatric patients with CAP.
More articles on antibiotics:
Administering antibiotics in infancy linked to early childhood obesity, study finds
Are viruses the new antibiotics?
Unnecessary antibiotic use leads to more than $163M in spending waste
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
